$BUD

Anheuser-Busch is investing $21 million in its Los Angeles and Mira Loma, California, facilities to expand production of Michelob ULTRA, Cutwater, and Phorm Energy, upgrade packaging and rail capacity, and enhance workforce training. This is part of a $600 million U.S. investment program for 2025-2026.

Deutsche Bank upgraded Anheuser-Busch InBev (ABI) to €79 and Campari to €7.1, citing optimism in beer and soft drinks. Carlsberg's target was cut to DKK1,160. Coca-Cola Europacific's target was raised to $117. Diageo, Heineken, and Pernod Ricard were kept at 'hold' with adjusted targets. The broker is cautious on spirits but constructive on soft drinks.

UBS assigned a Buy rating to Anheuser-Busch InBev SA/NV (ABI.BR) based on a weighted average of ratings including valuation, EPS revisions, and visibility. The company's stock is currently trading at 67.50 EUR, up 0.24% over 5 days but down 1.89% year-to-date, with a 23.06% increase since January 1st.

AB InBev is shifting its India strategy to target rural and semi-urban markets, driven by 20% growth in premium beer sales. The company is expanding its distribution network to 10 states, supported by favorable tax reforms in Karnataka and Maharashtra. However, it is withholding investments in Uttar Pradesh due to pricing restrictions. Globally, AB InBev reduced its net debt-to-EBITDA ratio to 2.86x, but faces antitrust investigations and inflationary pressures.

Anheuser-Busch sold its Merrimack plant to United Therapeutics for $47.5M. The 300-acre property, restricted from alcohol production for 5 years, is set for redevelopment. Anheuser-Busch InBev closed the plant in December, affecting 125 jobs.

Anheuser-Busch (BUD) plans to invest $13 million in its New York facility to boost production of Michelob ULTRA and Cutwater, its fastest-growing brands. The move aligns with its strategy to focus on high-growth brands, following a strong Q2 performance with 11% revenue growth. However, the company faces risks from shifting consumer preferences away from alcohol.

Anheuser-Busch InBev (AB InBev) is investing $13 million in its New York facility to expand production of Cutwater spirits RTDs and Michelob Ultra beer. This is part of a $300 million US production investment plan for the year. According to the company, Cutwater is experiencing rapid sales growth and is the top share-gaining brand in the US spirits industry. The investment will also upgrade production lines and establish a technical skills training center. AB InBev's CEO, Michel Doukeris, expres

Anheuser-Busch (BUD) is investing $13 million in its Baldwinsville, NY brewery to expand production of Michelob ULTRA and Cutwater, and to add a technical skills training center. This is part of a $600 million U.S. investment initiative through 2026, aiming to boost manufacturing capabilities and workforce development.

Bernstein rates four global beer companies “outperform” despite weak U.S. beer volumes. Nielsen data for 12 weeks to 8-Aug-26 show industry volumes down 6% YoY, linked to gas prices. AB InBev, Constellation, Diageo, and Heineken are cited for share gains and brand execution, with specific share/brand moves reported.

Zacks upgraded Anheuser-Busch InBev (BUD) to a Zacks Rank #2 (Buy), citing upward earnings estimate revisions. For FY ending Dec 2026, EPS is expected at $4.39 per share, unchanged from the prior year, while the Zacks Consensus Estimate rose 2.4% over the past three months. The article links estimate changes to near-term stock moves.